Developing combination immunotherapies for type 1 diabetes: recommendations from the ITN-JDRF Type 1 Diabetes Combination Therapy Assessment Group (Q84567639)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 May 2010

Language	Label	Description	Also known as
English	Developing combination immunotherapies for type 1 diabetes: recommendations from the ITN-JDRF Type 1 Diabetes Combination Therapy Assessment Group	scientific article published on 01 May 2010

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20629979%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Developing combination immunotherapies for type 1 diabetes: recommendations from the ITN-JDRF Type 1 Diabetes Combination Therapy Assessment Group (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20629979%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

type-1 diabetes

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

J B Matthews

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20629979%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

T P Staeva

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20629979%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

P L Bernstein

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20629979%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

M Peakman

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20629979%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

M von Herrath

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20629979%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

ITN-JDRF Type 1 Diabetes Combination Therapy Assessment Group

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20629979%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

publication date

1 May 2010

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20629979%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Clinical and Experimental Immunology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20629979%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

160

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20629979%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

176-184

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20629979%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20629979%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function

1 reference

https://pubmed.ncbi.nlm.nih.gov/20629979

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Surrogate end points in the design of immunotherapy trials: emerging lessons from type 1 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/20629979

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genetic-induced variations in the GAD65 T-cell repertoire governs efficacy of anti-CD3/GAD65 combination therapy in new-onset type 1 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/20629979

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Failure to preserve beta-cell function with mycophenolate mofetil and daclizumab combined therapy in patients with new- onset type 1 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/20629979

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Beta-cell activity and destruction in type 1 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/20629979

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination therapy with sirolimus and interleukin-2 prevents spontaneous and recurrent autoimmune diabetes in NOD mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/20629979

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/20629979

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Guidelines for Intervention Trials in Subjects With Newly Diagnosed Type 1 Diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/20629979

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of Cyclosporine Immunosuppression in Insulin-Dependent Diabetes Mellitus of Recent Onset

1 reference

https://pubmed.ncbi.nlm.nih.gov/20629979

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Factors associated with early remission of type I diabetes in children treated with cyclosporine

1 reference

https://pubmed.ncbi.nlm.nih.gov/20629979

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double-blind controlled trial of azathioprine in children with newly diagnosed type I diabetes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20629979

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Limited duration of remission of insulin dependency in children with recent overt type I diabetes treated with low-dose cyclosporin

1 reference

https://pubmed.ncbi.nlm.nih.gov/20629979

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunosuppressive drugs and the risk of cancer after organ transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20629979

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A single course of anti-CD3 monoclonal antibody hOKT3gamma1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/20629979

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/20629979

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration?

1 reference

https://pubmed.ncbi.nlm.nih.gov/20629979

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Targeting type 1 diabetes before and at the clinical onset of disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20629979

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-CD3 and nasal proinsulin combination therapy enhances remission from recent-onset autoimmune diabetes by inducing Tregs

1 reference

https://pubmed.ncbi.nlm.nih.gov/20629979

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Translational mini-review series on type 1 diabetes: Immune-based therapeutic approaches for type 1 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/20629979

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Are insights gained from NOD mice sufficient to guide clinical translation? Another inconvenient truth

1 reference

https://pubmed.ncbi.nlm.nih.gov/20629979

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Exendin-4 improves reversal of diabetes in NOD mice treated with anti-CD3 monoclonal antibody by enhancing recovery of beta-cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/20629979

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential gene expression profiles are dependent upon method of peripheral blood collection and RNA isolation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20629979

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

GAD treatment and insulin secretion in recent-onset type 1 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/20629979

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Post-mortem analysis of islet pathology in type 1 diabetes illuminates the life and death of the beta cell

1 reference

https://pubmed.ncbi.nlm.nih.gov/20629979

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of islet inflammation in human type 1 diabetes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20629979

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proinsulin peptide immunotherapy in type 1 diabetes: report of a first-in-man Phase I safety study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20629979

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

How can we improve the translational landscape for a faster cure of type 1 diabetes?

1 reference

https://pubmed.ncbi.nlm.nih.gov/20629979

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of patients with new onset Type 1 diabetes with a single course of anti-CD3 mAb Teplizumab preserves insulin production for up to 5 years

1 reference

https://pubmed.ncbi.nlm.nih.gov/20629979

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Validity and reproducibility of measurement of islet autoreactivity by T-cell assays in subjects with early type 1 diabetes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20629979

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of exenatide alone and in combination with daclizumab on beta-cell function in long-standing type 1 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/20629979

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1365-2249.2010.04153.X

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20629979%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

0 references

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20629979%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q84567639&oldid=1470239286"